Prevalence of Diabetic Peripheral Neuropathy and Its Association With Vitamin B12 Deficiency and Health-Related Quality of Life

Authors

DOI:

https://doi.org/10.14740/jem1582

Keywords:

Diabetic peripheral neuropathy, Vitamin B12 deficiency, Health-related quality of life, SF-36

Abstract

Background: The aim of the study was to determine the prevalence of diabetic peripheral neuropathy and vitamin B12 deficiency, their associated factors, and impact on health-related quality of life in a sample from the Dominican Republic.

Methods: A total of 367 patients with diabetes were recruited. The Toronto Clinical Scoring System (TCSS) was used to evaluate the presence of neuropathy symptoms, while the 36-Item Short Form Health Survey (SF-36) was used to assess health-related quality of life.

Results: Of the participants, 33.5% had neuropathy according to TCSS scores. Only one participant reported having a previous diagnosis of neuropathy. Factors associated with neuropathy were age, chronic renal insufficiency, and history of stroke. The prevalence of vitamin B12 deficiency was 4.5%, and no association was found with neuropathy. The presence of neuropathy significantly affected (P < 0.05) all physical dimensions of the SF-36 and the vitality dimension. Factors associated with the Physical Component Score (PCS) were age, neuropathy, and total number of comorbidities; factors associated with Mental Component Score (MCS) were age, sex, and being widowed.

Conclusions: The prevalence of neuropathy was high and its impact on QoL was significant. Almost none of the patients in which neuropathy was detected had a previous diagnosis. Considering this, the development of awareness and prevention interventions among both doctors and patients in the Dominican context is of utmost importance.

Downloads

Published

2025-12-24

Issue

Section

Original Article

How to Cite

1.
Calderon B, Soto M, Garcia N, Ghazanfari S, Velez J, Hasbun S. Prevalence of Diabetic Peripheral Neuropathy and Its Association With Vitamin B12 Deficiency and Health-Related Quality of Life. J Endocrinol Metab. 2025;15(5):181-190. doi:10.14740/jem1582